Comprehensive Management of Sjögren's Syndrome

Initial Diagnostic Workup

• The American Thoracic Society recommends that all patients with suspected or confirmed Sjögren's syndrome should undergo baseline chest radiography to screen for pulmonary involvement 1, 2
• Baseline complete pulmonary function tests (PFTs) should be considered even in asymptomatic patients to identify subclinical disease and establish a baseline for future comparisons 1, 3

Organ-Specific Evaluation

Pulmonary Assessment

• For patients with respiratory symptoms, complete PFTs and high-resolution CT (HRCT) are strongly recommended 1, 3, 2
• Bronchoscopy with bronchoalveolar lavage (BAL) should not be performed routinely but reserved for specific circumstances such as ruling out infectious etiologies in immunosuppressed patients 1

Ocular Assessment

• Objective parameters to evaluate include tear film stability, tear osmolarity, degree of lid margin disease, and ocular surface damage 4
• Diagnostic tests include tear break-up time test, ocular surface dye staining, Schirmer test, and tear osmolarity test 4

Treatment Approaches

Management of Sicca Symptoms

• The American Academy of Ophthalmology recommends first-line treatment with artificial tears and ocular gels/ointments for ocular dryness 4, 5
• For moderate to severe cases of ocular dryness, topical anti-inflammatory therapy (cyclosporine) may be considered 4

Management of Airway Disease

• For symptomatic vocal cord cystic lesions, less aggressive interventions such as voice therapy, inhaled corticosteroids, and intra-lesional corticosteroid injection should be considered before surgical resection 6, 7
• Empiric therapy for dry, nonproductive cough may include humidification, secretagogues, and guaifenesin after excluding other causes 6, 7

Systemic Therapy

• Hydroxychloroquine may be prescribed for fatigue and arthralgias, though evidence for efficacy in dry eye is limited 4
• For active systemic disease, treatment should be tailored to organ-specific severity using the EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) 5

Monitoring and Follow-up

• Regular assessment of disease activity using validated tools such as the ESSDAI for systemic activity is recommended 5
• For patients with pulmonary involvement, repeat PFTs every 6-12 months to track disease trajectory 2

Diagnostic Workup for Sjögren's Syndrome

Objective Assessment of Glandular Function

• Baseline evaluation of salivary gland function by measuring whole salivary flows, as recommended by the European League Against Rheumatism, can help assess gland function 8, 9
• Salivary scintigraphy may be considered to assess gland function, according to the European League Against Rheumatism, to evaluate salivary gland function 9

Systemic Evaluation

• Monitor for signs of systemic involvement, including fevers, night sweats, and lymphadenopathy, as suggested by the European League Against Rheumatism, to identify potential complications 10, 11

Disease Activity Assessment

• Use validated tools such as EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) to measure systemic activity, as recommended by the European League Against Rheumatism, to assess disease severity 10
• Evaluate severity of dryness, fatigue, and pain using EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), as suggested by the European League Against Rheumatism, to monitor patient-reported symptoms 12

Monitoring for Complications

• Regular assessment for lymphoma development (2-5% risk) through clinical examination for lymphadenopathy and monitoring of laboratory parameters, as recommended by the European League Against Rheumatism, to identify potential lymphoma risk 11